Imax Corp
10 nominees · 3 ballot items.
Elect ten directors; appoint PricewaterhouseCoopers LLP as independent auditors and authorize directors to fix their remuneration; and conduct an advisory (non-binding) vote to approve Named Executive Officer compensation as disclosed in the proxy.
Follow how the vote landed and what changed on Imax Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of the Ten Nominees for the Board of Directors
ManagementBoard: FORElect ten individuals nominated to serve as directors until the close of the next annual general meeting or until their successors are elected or appointed.
- 2
Appointment of PricewaterhouseCoopers LLP as the Company's Independent Auditors
ManagementBoard: FORApprove the appointment of PricewaterhouseCoopers LLP as the Company's independent auditors until the next annual general meeting and authorize the directors to fix the auditors’ remuneration.
- 3
Advisory Vote on Named Executive Officer Compensation ("Say-on-Pay
ManagementBoard: FORAdvisory (non-binding) vote to approve the compensation of the Company’s Named Executive Officers as disclosed in the Compensation Discussion and Analysis, compensation tables, and related narrative in the proxy.
More detail
This advisory proposal asks shareholders to approve, on a non-binding basis, the Company’s executive compensation program as described in the Compensation Discussion and Analysis and related disclosure. Management seeks this endorsement to validate its pay-for-performance framework, which mixes short-term cash incentives and long-term equity (PSUs and RSUs) tied to quantitative metrics (Total Revenue, Installations, Total Adjusted EBITDA Growth and Margin, Signings, Adjusted EPS, and Relative TSR) and qualitative business-unit and individual assessments. The Compensation Committee emphasizes robust shareholder engagement — contacting holders of ~67% of shares in 2025 and reporting broad support, including 95% approval at the 2025 meeting — and says it has incorporated feedback (for example, adding Adjusted EPS to the annual bonus scorecard). In 2025 pay outcomes were above-target (annual bonuses paid at 119%–158% of target and 2023 PSUs paid at 165% of target) reflecting record company performance (record box office, revenue, margin expansion, and network growth). Management also recently amended the CEO’s employment agreement to increase his equity grant opportunity (delivered in long-term incentives) and to align certain vesting/service provisions, which the Board presents as reinforcing long-term alignment despite legacy change‑in‑control terms that remain. The vote is non-binding, but the Board and Compensation Committee state they will review results and consider shareholder views in future decisions. For an investor evaluating the proposal, key considerations include the demonstrated strong company performance and high historical shareholder support, the alignment of pay to multi-year performance via PSUs and TSR-relative measures, the recent increase in CEO long-term pay (higher equity target and PSU maximum), and governance signals such as shareholder outreach and clawback and anti-hedging policies; potential concerns include the retention of certain legacy change-in-control provisions for the CEO and the discretion in qualitative bonus components. Overall, the Board frames the proposal as a confirmation of a compensation program that has delivered significant shareholder value while preserving flexibility to retain and incentivize required executive talent.
Nominees on the ballot10
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Orbis Allan Gray Ltd | 9.4% | 5,131,901 | $195M |
| 2 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 6.8% | 3,704,207 | $141M |
| 3 | WESTFIELD CAPITAL MANAGEMENT CO LP | 4.3% | 2,338,776 | $89M |
| 4 | DRIEHAUS CAPITAL MANAGEMENT LLC | 3.0% | 1,651,711 | $63M |
| 5 | BlackRock, Inc. | 2.8% | 1,563,089 | $59M |
| 6 | CONGRESS ASSET MANAGEMENT CO | 2.8% | 1,510,375 | $57M |
| 7 | FMR LLC | 2.7% | 1,461,735 | $56M |
| 8 | AMERIPRISE FINANCIAL INC | 2.3% | 1,247,141 | $47M |
| 9 | ROYCE ASSOCIATES LP | 2.3% | 1,246,240 | $47M |
| 10 | DIMENSIONAL FUND ADVISORS LP | 2.1% | 1,170,744 | $44M |
Other Communication Services sector meetings6
Upcoming shareholder meetings at Imax Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Imax Corp 2026 annual meeting?
- Imax Corp (IMAX) holds its 2026 annual shareholder meeting on Wednesday, June 10, 2026.
- What is the record date for the Imax Corp 2026 meeting?
- The record date for the Imax Corp 2026 meeting is Monday, April 13, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Imax Corp's 2026 meeting?
- The board is presenting 10 director nominees at the Imax Corp 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Imax Corp 2026 meeting?
- Shareholders will vote on 3 proposals at the Imax Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.